Barclays PLC Has $9.71 Million Position in Option Care Health, Inc. (NASDAQ:OPCH)

Barclays PLC boosted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 180.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 310,194 shares of the company’s stock after acquiring an additional 199,454 shares during the period. Barclays PLC owned 0.18% of Option Care Health worth $9,708,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. UMB Bank n.a. raised its holdings in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares during the period. GAMMA Investing LLC increased its position in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. raised its stake in Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the period. International Assets Investment Management LLC grew its stake in Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares during the period. Finally, Blue Trust Inc. grew its stake in Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares during the period. Institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on OPCH. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and lowered their target price for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Truist Financial cut their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Barrington Research lowered their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Finally, Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Option Care Health has an average rating of “Hold” and a consensus target price of $30.14.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Stock Down 0.1 %

OPCH opened at $23.46 on Tuesday. The stock’s fifty day simple moving average is $25.30 and its 200 day simple moving average is $28.42. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63. The stock has a market cap of $3.99 billion, a PE ratio of 19.71, a price-to-earnings-growth ratio of 2.45 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.